FdaApplication
NDA 219208
Identifiers
- fda_app_no: NDA219208
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2025-04-02 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VANRAFIA | ATRASENTAN HYDROCHLORIDE | EQ 0.75MG BASE | TABLET;ORAL |
1 product